Compositions and Methods for Treating Hemorrhagic Shock
AssigneeVirTech Bio, Inc.
InventorWilliam Richard Light, III
Life of this patent
Estimating the term…
Abstract
Pharmaceutical formulations to prevent or treat hemorrhagic shock are provided. The pharmaceutical formulations comprise an oxygenation complement comprising a hemoglobin-based oxygen carried (HBOC) and blood plasma. Related methods to prepare the pharmaceutical preparations are also provided. Furthermore, methods to prevent or treat hemorrhagic shock are provided.
Claims36
A liquid pharmaceutical formulation comprising an oxygenation complement comprising a hemoglobin-based oxygen carrier (HBOC) and blood plasma.
A method for preventing or treating hemorrhagic shock, the method comprising intravenously administering to a subject in need thereof an effective amount of an oxygenation complement comprising a hemoglobin-based oxygen carrier (HBOC) and blood plasma, in an effective amount to prevent or treat hemorrhagic shock in the subject.
A liquid low ionic solute HBOC preparation comprising no more than about than about 27 milliequivalent (mEq/L) sodium ions (Na+), no more than about 0.7 mEq/L potassium ions (K+) ions, no more than about 0.92 mEq/L calcium ions (Ca2+), no more than about 0.3 mEq/L magnesium ions (Mg2+) ions, no more than about 19.2 mEq/L chloride ions (Cl−) ions, no more than 4.8 mEq/L bicarbonate ions (HCO32−), and no more than about 0.5 mEq/L hydrogen phosphate ions (HPO42−).
Dependencies are inferred from the claim text.